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1. Introduction 
Aerobic organisms require ground state oxygen to live. However, the use of oxygen during 
normal metabolism produces reactive oxygen species (ROS), some of which are highly toxic 
and deleterious to cells and tissues because of the ability to react with and alter all principal 
molecules of the cell, including lipids, proteins, carbohydrates and nucleic acids. It has been 
estimated that a human cell is affected by 1.5 x 105 oxidative strokes per day (Beckman & 
Ames, 1997). Under normal conditions, damage by oxygen radicals is kept in check by an 
efficient array of antioxidant (AO) mechanisms, such as AO enzymes superoxide dismutase 
(SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione reductase (GR), as well 
as nonenzymatic scavengers. Although potentially deleterious, ROS also have important 
beneficial functions as a part of protective mechanism against microorganisms and serving 
as cell signaling molecules.  
1.1 Reactive oxygen species (ROS) 
The term "reactive oxygen species" is used for a group o f chemical species that contain 
oxygen and are characterized by a high reactivity towards inorganic molecules, as well as 
biomolecules. ROS are: 
 molecules, such as hydrogen peroxide (H2O2), 
 ions, such as hypochlorite anion (OCl-), 
 free radicals, like hydroxyl radical (OH.),  
 superoxide anion radical, which is an anion and a radical (O2.-). 
Free radicals are molecules that contain one or more unpaired electrons in outer orbit 
(Halliwell & Gutteridge, 1989). The presence of the unpaired electron makes them highly 
reactive, which means that they can react with the majority of surrounding molecules 
 
Celiac Disease – From Pathophysiology to Advanced Therapies 
 
18
including proteins, lipids, carbohydrates and nucleic acids. Tending to obtain a stable state, 
they "attack" the nearest stable molecule "stealing" an electron. When the "attacked" 
molecule loses an electron, it becomes a free radical itself, beginning a chain reaction that 
may end with the destruction of a living cell. The most important free radicals in biological 
systems are O2.-, OH., nitric oxide (NO.), lipid peroxyl radical (ROO.) and alkoxyl radical 
(RO.).  
1.1.1 The activation of oxygen 
Atmospheric oxygen in its basic state is unique among other gaseous elements, because it is 
a biradical, which means that in its outer orbit it has two unpaired electrons with parallel 
spins (a "triplet state" 3O2). Due to this feature oxygen can hardly react with organic 
molecules, unless it is previously activated (Elstner, 1987). If a biradical form of oxygen 
absorbs energy sufficient to change the spin of one of the unpaired electrons, a “singlet 
state” (1O2*) is generated, having two electrons with opposite spins. The oxygen thus 
activated can participate in reactions involving simultaneous transfer of two electrons 
(divalent reduction). Since paired electrons are usual in organic molecules, singlet oxygen is 
more reactive towards organic molecules than oxygen in the basic state.  The other 
mechanism of activation is a gradual monovalent reduction of oxygen, generating O2.-, 
H2O2, OH. and in the end H2O.  
1.1.2 Sources of ROS 
Free radicals and ROS can originate via action of various endogenous and exogenous 
factors. Endogenous sources of ROS are autoxidation of different organic and inorganic 
molecules, enzymatically catalyzed oxidation and the "respiratory burst". Superoxide anion 
radical is the most common oxidant produced by normal cell metabolism. The main sources 
of O2.- are electron transport systems in membranes of mitochondria and other organelles 
(endoplasmic reticulum, chloroplasts). Apart from the mitochondrial respiratory chain, an 
array of nonenzymatic and enzymatic reactions can be the source of ROS. Autoxidation of 
various cell molecules (quinones, thiols, flavines, catecholamines, hemoglobin, myoglobin) 
produce O2.-. Ferrous ions are also subjected to autoxidation followed by ROS production. 
ROS may be a direct product of enzymatic reactions. Myeloperoxidase in neutrophils in the 
presence of chloride produces OCl- from H2O2. Xanthine oxidase (XO) catalyzes oxidation of 
hypoxanthine to xanthine and xanthine to uric acid, producing O2.- and H2O2 (Valko et al., 
2004). Certain cells of the immune system (neutrophils, eosinophils, mononuclear 
phagocytes, B lymphocytes) during phagocytosis produce ROS (OCl-, OH., 1O2* or 
chloramines) as microbicidal agents. A precursor of more reactive oxidants is O2.-, whose 
production is associated with increased oxygen consumption in these cells sometimes even 
up to 50 times and this metabolic process is known as the "respiratory burst" (Babior, 1984). 
Exogenous sources of ROS are drugs, radiation and smoking. Certain drugs such as some 
antibiotics and antineoplastic agents (anthracyclines, methotrexate) may increase ROS 
production under hyperoxic conditions (Gressier et al., 1994). In addition, components of 
some drugs may deplete AO reserves, enhancing effects of lipid peroxidation (Grisham et 
al., 1992). Radiotherapy can cause free radical production. Electromagnetic and particle 
irradiation produce primary radicals transferring their energy to the cell molecules. Tobacco 
smoke contains a great amount of oxidants. It has been suggested that 1014 different oxidants 
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such as aldehydes, epoxides, peroxides, quinones, hydroquinones, NO. etc., are being 
imported in organism by just one breath of cigarette smoke (Church & Pryor, 1985). 
1.1.3 Effects of ROS 
One of the most important effects of ROS is oxidative damage of polyunsaturated fatty acids 
(PUFA) in cell membrane lipids. This process is known as lipid peroxidation (LPO). It is a 
chain reaction that provokes changes in the membrane phospholipid bilayer structure and 
modifies membrane proteins, causing loss of membrane elasticity and selective permeability 
and disruption of its other functions (Spiteller, 2007). The damage provoked by LPO can be 
prevented by chain-breaking antioxidants (-carotene, lycopene, vitamins A, C, E). Strong 
oxidants, such as OH. can react with all components of the DNA molecule, causing single- or 
double-strand breaks and an increased rate of mutations (Egler et al., 2005). Permanent 
modifications of the genetic material represent the first step towards mutagenesis, 
carcinogenesis and aging. Proteins can also be oxidized by strong oxidants. Amino acids 
containing sulfur, especially the thiol group (-SH), are particularly susceptible to ROS. 
Oxidants can activate or inactivate proteins by oxidizing –SH groups and modifying amino 
acids (Davies, 1987). As a consequence of the deleterious effects of ROS, necrotic cell death 
may ensue. In addition, ROS and changes in cellular redox state may play a crucial role in 
the regulation and initiation of processes associated with apoptosis (Kroemer et al., 1998; 
Mignotte & Vayssiere, 1998).  
Although a great importance is given to the negative effects of ROS, they also have 
beneficial physiological functions in the cell. Their role in the defense against 
microorganisms is indispensible. During phagocytosis activated inflammatory cells produce 
ROS to kill microbes. ROS can also have a critical role in signal transduction and redox 
regulation of gene expression (Thannickal & Fanburg, 2000) and the regulation of cell 
growth and proliferation (Burdon, 1996). 
1.2 Antioxidant defense system 
Detoxification of ROS is a sine qua non of aerobic life, hence a complex AO system has 
evolved due to evolutionary pressures. Antioxidants are agents which scavenge ROS, inhibit 
their production and/or repair the damage they have caused (Halliwell, 1991). The AO 
system involve AO enzymes (SOD, CAT, GPx), nonenzymatic antioxidants (glutathione 
(GSH), vitamin C, vitamin E, -carotene, flavonoids), auxiliary enzymes that regenerate 
active forms of antioxidants (GR, glutathione-S-transferase (GST), glucose-6-phosphate 
dehydrogenase (G6PDH)), as well as metal binding proteins (transferrin, cerruloplasmin, 
albumin). 
SOD catalyzes dismutation of O2.- to H2O2 and oxygen. This reaction is 104 times faster than 
spontaneous dismutation. In humans three different forms of this enzyme exist: cytosolic or 
copper, zinc SOD (CuZnSOD), mitochondrial or manganese SOD (MnSOD) and 
extracellular SOD (ECSOD). Catalase catalyzes decomposition of H2O2 to water and oxygen. 
The glutathione redox cycle is a key mechanism for protection of cell membranes from 
damage by LPO. This cycle involves enzymes GPx, which uses GSH to reduce organic 
peroxides and hydrogen peroxide and GR, which reduces the oxidized form of glutathione 
(GSSG) with concomitant oxidation of NADPH. In a wider sense this cycle also includes the 
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enzymes that synthesize GSH (-glutamylcysteine synthetase and GSH synthetase), G6PDH, 
which regenerates NADPH, as well as GST. GSH is a potent antioxidant, antitoxin and 
enzymatic cofactor. It can directly react with free radicals. GSH has also an important role in 
regenerating active forms of other antioxidants such as vitamins E and C and carotenoids 
(Jones et al., 2000). 
1.3 The role of oxidative stress in the pathogenesis of gastrointestinal diseases 
The oxidant versus AO balance may be altered in various pathological conditions, primarily 
or secondarily. If ROS production overwhelms the AO defense capacity of a cell, oxidative 
damage occurs and the condition is known as oxidative stress. Oxidative stress plays an 
important role in the pathogenesis of many diseases including various gastrointestinal 
disorders. It has been shown that the concentration of ROS is elevated in patients with 
various liver diseases such as alcoholic hepatitis and cirrhosis, while antioxidant therapy  
has protective effects in animal models of these disorders (Dryden et al., 2005). Colon 
cancer, as well as acute and chronic pancreatitis, have also been associated with oxidative 
stress (Dryden et al., 2005; Opara, 2003). It has been suggested that oxidative stress may 
have an important role in the pathogenesis of acquired megacolon, since decreased AO 
levels provoke changes in the intestinal levels of inhibitory neurotransmitters in patients 
affected by the disease (Koch et al., 1996). Necrotizing enterocolitis, a severe disorder found 
in infants, is another disease whose pathogenesis is attributed to oxidative stress (Otamiri & 
Sjödahl, 1991). Helicobacter pylori infection, an important factor in the pathogenesis of gastric 
cancer, is also followed by an increased production of ROS (Farinati et al., 2003).  
The role of oxidative stress in pathological changes in gastrointestinal tract has mostly been 
studied in inflammatory bowel disease (IBD) such as ulcerative colitis and Crohn's disease. 
It has been suggested that oxidative stress plays an important role in the initiation, as well as 
progression of IBD and antioxidant therapy, for e.g. use of green tea polyphenols or SOD, 
significantly attenuates the disorder (Dryden et al., 2005). IBD is characterized by elevation 
in mucosal inflammatory cells, leading to disruption of the epithelial barrier. This allows 
highly immunogenic bacterial antigens, present in the intestinal lumen in high 
concentrations, to enter the normally sterile subepithelial layers, activating a cascade of 
destructive immunologic responses (Rezaie et al., 2007). Various theories regarding the 
initiation of the inflammatory response in the intestinal mucosa have been proposed, but 
none of them is universally accepted (Hendrickson et al., 2002). Many studies have reported 
the increased concentrations of oxidized biomolecules and the decreased concentrations of 
various antioxidants in patients affected by IBD, not only in the intestinal mucosa, but also 
in other parts of the gastrointestinal tract, as well as in the blood and respiratory system 
(Rezaie et al. 2006). It is known that oxidizing agents can induce clinical and histological 
alterations characteristic of IBD (Bilotta & Waye, 1989; Meyer et al. 1981). ROS may damage 
intestinal mucosa and increase its permeability (Rao et al., 1997; Riedle & Kerjaschki, 1997). 
In addition, it has been shown that patients affected by Crohn's disease in latent phase, as 
well as their first-degree relatives, have increased intestinal permeability without 
inflammation. The fact that oxidative stress is present in the bowel before the beginning of 
the inflammatory cascade suggests that ROS are not collateral products of the inflammatory 
process, but play an important role in the pathogenesis of the disease (Buhner et al. 2006; 
Fries et al., 2005). 
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1.4 Oxidative stress and antioxidant status of patients with celiac disease 
There is a growing body of evidence indicating that oxidative stress and the cellular redox 
status are also implicated in the pathogenesis of celiac disease. The results of various 
investigations suggest that gliadin disturbs the pro-oxidant-antioxidant balance in small 
intestinal mucosa of affected persons through overproduction of ROS (Boda et al., 1999; 
Dugas et al., 2003). Several in vitro studies have also reported redox imbalance and 
increased levels of free radicals after exposure of cells to gliadin (Dolfini et al., 2002; Maiuri 
et al., 2003; Rivabene, 1999; Tucková et al., 2002).  
Data concerning the AO status of celiac patients are scarce. The results of a few 
investigations indicate that the AO capacity of celiac patients is diminished. Odetti et al. 
(1998) found a lowered level of vitamin E and increased levels of markers of oxidized lipids 
and proteins in the plasma of celiac patients subjected to gluten free diet, while Ståhlberg et 
al. have reported decreased GSH concentrations and GPx activity in erythrocytes and the 
small intestinal mucosa of children affected by celiac disease (Ståhlberg et al., 1988; 
Ståhlberg & Hietanen, 1991). In our previous papers (Stojiljković et al., 2007; Stojiljković et 
al., 2009) we showed that oxidative stress is strongly associated with CD and that the AO 
capacity of celiac patients is weakened by a depletion of GSH and reduced activities of GSH-
dependent AO enzymes GPx and GR. In this study we describe the results of our 
investigation regarding the AO status of celiac patients with different degrees of severity of 
the mucosal lesion. The activities of AO enzymes MnSOD, CuZnSOD, CAT, GPx and GR, as 
well as the concentrations of GSH and lipid hydroperoxides (LOOH) were examined. 
2. Materials and methods 
2.1 Subjects 
The study involved small intestinal biopsies from 55 children affected by celiac disease (24 
boys, 31 girls; median age 8 years; range 1.5-16 years) who were attended at the University 
Children's Hospital, Belgrade, Serbia, between September 2003 and December 2006. Clinical 
characteristics of the patients are described in Table 1. Twenty six children were diagnosed 
in early childhood and by the time of sampling, they had been subjected to gluten-free diet 
(GFD) for 2-4 years. In the other 29 children, who were using gluten containing diet, the 
diagnosis was made at the time of the study. Among them, 18 children had active form of 
the disease with typical symptoms (chronic diarrhea, fatigue, failure to thrive or weight 
loss), while 11 children were asymptomatic. Typical villous atrophy was found on 
examination of intestinal biopsy specimens in all children on the gluten containing diet. The 
diagnosis of celiac disease was based on the revised criteria of the European Society for 
Paediatric Gastroenterology, Hepatology and Nutrition (Walker-Smith, 1990). The Ethical 
Committee of the Faculty of Medicine, University of Belgrade, approved the study. The 
parents of all patients included in the study gave written informed consent.  
Histological evaluation was performed according to the modified Oberhuber-Marsh 
classification (Oberhuber et al., 1999). Patients were divided in 4 groups. In the Marsh 0 
group, the mucosa was normal with no signs of inflammation (n = 17, all on GFD). In the 
Marsh 1+2 group, the mucosa was characterized by intraepithelial lymphocytosis (Marsh 1) 
or intraepithelial lymphocytosis accompanied by crypt hyperplasia (Marsh 2) (n = 9, six 
Marsh 1 and three Marsh 2, all on GFD). In the Marsh 3a group (n=20, seven asymptomatic 
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and 13 with active celiac disease) partial villous atrophy was present, while in the Marsh 3b 
group (n=9, four asymptomatic and five with active form of the disease) subtotal villous 
atrophy was found. 
 
 
Patients 
active asymptomatic GFD 
Number 18 11 26 
Gender 
   Male 
   Female 
 
6 
12 
 
6 
5 
 
12 
14 
Age (years) 
   Range 
   Median 
 
1,5-15 
4,63±1,19 
 
1,5-16 
8,34±1,36 
 
5-16 
8,78±1,24 
Body mass index 
   <15th percentile 
   15-75th percentile 
   >75th percentile 
 
10 
7 
1 
 
3 
8 
- 
 
5 
13 
8 
Hemoglobin (g/L)1 102.8±3.6 119.2±4.0 ** 133.3±4.1*** # 
Mean cell volume (fL)2 70.1±2.6 73.8±3.5 76.7±1.6* 
serum iron (mol/L) 3 5.5±0.7 10.9±2.6** 17.6±3.5*** # 
1Normal value: 120-170 g/L  
2Normal value:  86-98 fL 
3Normal value: 10-22 mol/L 
Table 1. Clinical characteristics of patients affected by celiac disease. Hemoglobin, mean cell 
volume and serum iron are means ± SEM. Statistical significance: *** P < 0.001, ** P < 0.01, * 
P < 0.05, significantly different from active patients; # P < 0.05 significantly different from 
asymptomatic patients. GFD, patients on gluten-free diet.  
2.2 Sample preparation 
From each patient 6-8 proximal small intestinal biopsy specimens were obtained. Some of 
them were used for histopathological analysis and others were washed in ice-cold saline and 
frozen at -70 °C for SOD, CAT, GPx, GR, GSH and LOOH assays. One biopsy specimen from 
each patient was kept on -70 °C for the GSH assay, while others were thawed within a week 
and homogenized in 20 volumes of cold sucrose buffer pH 7.4. Homogenates were vortexed 
3 times for 15 seconds and then kept at -70 °C. Thawed homogenates were centrifuged 
(Eppendorf centrifuge 5417R, Eppendorf-Netheler-Hinz GmbH, Hamburg, Germany) at 
8600 g, 4 °C, for 10 minutes. Supernatants were stored at -70 °C. 
2.3 Assays 
All assays were performed using the Perkin Elmer Lambda 25 Spectrophotometer (Perkin 
Elmer Instruments, Norwalk, CT, USA). The specific enzyme activities of SODs and CAT 
were expressed as units per milligram of protein (U/mg) and of GPx and GR as milliunits 
per milligram of protein (mU/mg). The GSH and LOOH concentrations were expressed in 
micromoles per liter (mol/l). 
SOD assay. Total SOD activity was measured using the Oxis Bioxytech® SOD-525TM Assay (Oxis 
International, Inc., Portland, OR, USA). The method is based on the SOD-mediated increase in 
the rate of autoxidation of reagent 1 (5,6,6a,11b-tetrahydro-3,9,10-trihydroxybenzo[c]fluorene, 
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R1) in aqueous alkaline solution, yielding a chromophore with maximum absorbance at 525 nm. 
The kinetic measurement of the change in absorbance at 525 nm is performed. One SOD-525 
activity unit is defined as the activity that doubles the autoxidation rate of the control blank. 
CuZnSOD activity was measured as described above, after pretreating samples with ethanol-
chloroform reagent (5/3 vol/vol), which inactivates MnSOD. MnSOD activity was then 
calculated by subtracting CuZnSOD activity from total SOD activity. 
CAT assay. CAT activity was measured by the method of Beutler (1982), which is based on 
the measurement of the rate of H2O2 decomposition by catalase from the examined samples. 
The decomposition of H2O2 was demonstrated by a decrease in absorbance at 230 nm as a 
function of time. One CAT activity unit is defined as 1 mol of H2O2 decomposed per 
minute under the assay conditions. 
GPx assay. Gpx activity was determined by the Oxis Bioxytech® GPx-340™ Assay (Oxis 
International, Inc., Portland, OR, USA). Upon reduction of organic peroxide by GPx, 
oxidized glutathione (GSSG) is produced and its recycling to GSH by GR is accompanied by 
oxidation of nicotinamide adenine dinucleotide phosphate (NADPH) to NADP+. The rate of 
NADPH oxidation, followed by a decrease in absorbance at 340 nm as a function of time, is 
directly proportional to the GPx activity in the sample. One GPx-340 activity unit is defined 
as 1 mol of NADPH consumed per minute under the assay conditions. 
GR assay. The activity of GR was measured by the Oxis Bioxytech® GR-340™ Assay (Oxis 
International, Inc., Portland, OR, USA). The assay is based on the oxidation of NADPH to 
NADP+ by GR from the sample. The rate of NADPH oxidation was determined by the rate 
of a decrease in absorbance at 340 nm. One GR-340 unit is defined as 1 mol of NADPH 
oxidized per minute under the assay conditions. 
GSH assay. The concentration of GSH was determined by the Oxis Bioxytech® GSH-420™ 
Assay (Oxis International, Inc., Portland, OR, USA). The thawed tissue was homogenized in 
20 volumes of precipitating reagent (trichloroacetic acid) and homogenates were centrifuged 
at 3000 g, 4 °C, 10 minutes. Supernatants were used for GSH assay. The reaction is 
performed in three steps. The sample was first buffered and treated with the reducing agent 
(tris(2-carboxyethyl)phosphine) to reduce any oxidized glutathione present in the sample. 
Then the chromogen (4-chloro-1-methyl-7-trifluoromethylquinolinium methylsulphate) was 
added forming thioethers with all thiols from the sample. After addition of base to raise the 
pH over 13, a -elimination specific to the GSH-thioether results in the chromophoric thione. 
The absorbance at 420 nm is directly proportional to the GSH concentration. 
LOOH assay. The concentration of LOOH was determined by the Oxis Bioxytech® LPO-
560™ Assay (Oxis International, Inc., Portland, OR, USA). The assay is based on the 
oxidation of ferrous to ferric ions by LOOH from the sample under acidic conditions. Ferric 
ions bind with the indicator dye (xylenol orange) and a stable colored complex is formed. 
The absorbance at 560 nm is directly proportional to the LOOH concentration. To eliminate 
H2O2 interference the samples were pretreated with catalase.  
2.4 Statistics 
Differences between the groups were tested by the Kruskal-Wallis test. Multiple 
comparisons of the groups were performed by the Dunn test. Correlations between AO 
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parameters and the degree of mucosal lesion were evaluated by the Spearman’s rank order 
correlation coefficient rs. A P value lower than 0.05 was considered significant.  
3. Results  
All parameters, except CuZnSOD and CAT activity, varied significantly between the 
analyzed groups: MnSOD: H = 8.79, P < 0.05; CuZnSOD: H = 5.23, P > 0.05; CAT: H = 5.75, P 
> 0.05; GPx: H = 12.61, P < 0.01; GR: H = 9.81, P < 0.05; GSH: H = 32.70, P < 0.001; LOOH: H 
= 22.92, P < 0.001 (Kruskal-Wallis test). 
 
Fig. 1. The activities of manganese superoxide dismutase (MnSOD), copper-zink  SOD 
(CuZnSOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione reductase (GR) 
in normal intestinal mucosa (Marsh 0), mucosa with intraepithelial lymphocytosis or 
intraepithelial lymphocytosis accompanied by crypt hyperplasia (Marsh 1+2), mucosa with 
partial (Marsh 3a) or subtotal villous atrophy (Marsh 3b). Boxes represent values between 
25th and 75th percentile. Medians are given inside the boxes. Whiskers extend between min 
and max values. ** P < 0.01, * P < 0.05, significantly different from Marsh 0 group. 
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The activities of the AO enzymes are represented in Figure 1. In comparison to Marsh 0 
group, the MnSOD activity was significantly elevated in Marsh 3a group (P < 0.01). GPx 
activity was significantly lower in Marsh 3a (P < 0.01) and Marsh 3b groups (P < 0.05) than 
in Marsh 0. GR activity was also reduced in Marsh 3a (P < 0.01) when compared to Marsh 0. 
The patients with villous atrophy (Marsh 3a and 3b) had significantly reduced GSH level in 
comparison to the patients with normal mucosa (Marsh 0, P < 0.0001) or milder mucosal 
lesion (Marsh 1+2, P < 0.01). Significant increase in LOOH levels was found in Marsh 1+2 (P 
< 0.01), Marsh 3a and 3b (P < 0.001), comparing to the patients with normal mucosa. LOOH 
concentration was also higher in patients with villous atrophy than in patients with Marsh 
1+2 lesions (P > 0.05) (Figure 2). 
 
 
 
 
Fig. 2. Concentrations of glutathione (GSH) and lipid hydroperoxides (LOOH) in normal 
intestinal mucosa (Marsh 0), mucosa with intraepithelial lymphocytosis or intraepithelial 
lymphocytosis accompanied by crypt hyperplasia (Marsh 1+2), mucosa with partial (Marsh 
3a) or subtotal villous atrophy (Marsh 3b).  Boxes represent values between 25th and 75th 
percentile. Medians are given inside the boxes. Whiskers extend between min and max 
values. *** P < 0.001, ** P < 0.01, significantly different from Marsh 0 group; ## P < 0.01, # P < 
0.05, significantly different from Marsh 1+2 group. 
All investigated parameters correlated significantly with the degree of mucosal damage 
(Figure 3). Positive correlations were found between the severity of mucosal lesion and the 
activities of MnSOD (rs = 0.33, P < 0.01), CuZnSOD (rs = 0.27, P < 0.01) and CAT (rs = 0.25, P 
< 0.05). On the contrary, GSH concentration as well as the activities of GSH-related enzymes 
GPx and GR inversely correlated with degree of the mucosal lesion (rs = -0.67, P < 0.0001; rs 
= -0.40, P < 0.001; rs = -0.27, P < 0.05, respectively). In addition, significant positive 
correlation was found between the LOOH level and the degree of mucosal damage (rs = 
0.56, P < 0.0001). 
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Fig, 3. Data plot and coefficients of Spearman's rank correlation rs between the parameters of 
antioxidant status and the severity of mucosal lesion in celiac patients. MnSOD – manganese 
superoxide dismutase, CuZnSOD - copper-zink superoxid dismutase, CAT - catalase, GPx - 
glutathione peroxidase, GR  - glutathione reductase, GSH – glutathione,  LOOH - lipid 
hydroperoxides; Marsh 0 - normal intestinal mucosa, Marsh 1 - mucosa with intraepithelial 
lymphocytosis, Marsh 2 - mucosa with intraepithelial lymphocytosis accompanied by crypt 
hyperplasia, Marsh 3a - mucosa with partial villous atrophy, Marsh 3b - mucosa with 
subtotal villous atrophy. 
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4. Discussion 
There is a growing body of evidence showing that ROS are involved in the pathology of 
celiac disease. Pro-oxidant effects of gliadin have also been reported in celiac patients.  
Activation of XO is one of the mechanisms of free radical and ROS overproduction in the 
small intestinal mucosa. The xanthine oxidoreductase system is mainly located in the 
intestinal mucosa and liver (Sarnesto et al., 1996). Distribution of this enzyme in the small 
bowel is not uniform. Histological studies have shown that the main part of XO is located in 
the epithelial cells at the top of the intestinal villi, while no XO activity could be detected at 
the basis of crypts (Pickett et al., 1970). The results of Boda and coworkers (1999) suggest 
that in patients with active celiac disease, gluten ingestion, along with the resulting 
inflammation, causes activation of XO in enterocytes, which results in overproduction of 
ROS and further damage to the mucosa. These pro-oxidant processes are counteracted by 
AO enzymes MnSOD and CuZnSOD. The activity of MnSOD in our study was elevated in 
patients with villous atrophy comparing to the Marsh 0 group, while CuZnSOD activity did 
not vary significantly. However, positive correlations between the activities of both SODs 
and the degree of mucosal lesion indicate that more severe mucosal damage is associated 
with increased enzyme activities. This may represent a physiological response to a higher 
rate of ROS production. On the contrary, the activity of CAT did not vary significantly 
between the analyzed groups and it correlated inversely with the mucosal lesion. This may 
be a consequence of the kinetic characteristics of this enzyme. Namely, due to its high 
Michaelis-Menten constant, CAT is most efficient against high H2O2 concentrations. When 
H2O2 concentrations are lower, more effective protection is given by GPx, another H2O2 
detoxifying enzyme (Eaton, 1991). Since the activity of GPx, the main scavenger of H2O2 in 
gastro-intestinal tissue was significantly decreased in patients with villous atrophy (Marsh 
3a and Marsh 3b), the imbalance between H2O2 production and scavenging causes pro-
oxidant shift, which results in increased LPO and LOOH concentration. In these patients 
LOOH concentration was ~ 80 % higher than in patients with normal mucosa. Even in some 
GFD patients (Marsh 1+2) LOOH concentration was elevated ~ 20 % in comparison to the 
Marsh 0 group. These results are in accordance with the data from an in vitro study 
(Rivabene et al., 1999) where the concentration of LOOH in cell culture was 30-50 % higher 
after gliadin treatment. 
Increased LOOH levels may contribute to the disruption of detoxifying pathways in the 
bowel and to dysfunction of enterocytes, which may cause various disorders of the digestive 
tract (Aw, 1998). The intestine differs from other fully differentiated organs by a very high 
rate of cellular turn over. The lifespan of enterocytes is only 4-6 days (Iatropoulos, 1986). 
Due to the high cell division rate, the chance of spreading a mutation to the subsequent cell 
generations is much higher than in cells with a low division rate, which makes the intestine 
very susceptible to mutagenesis and cancerogenesis. It has been shown that subtoxic 
concentrations of LOOH can provoke a change in the cellular redox state enough to enhance 
a mitogenic response in rat enterocytes (Aw, 1999), while more severe oxidative stress 
activates pro-apoptotic processes (Imai & Nakagawa, 2003). Several in vitro studies have 
also demonstrated that exposure of human intestinal cells to the subtoxic concentrations of 
LOOH can induce cell transition from a quiescent to a proliferative state or even growth 
arrest (Gotoh et al., 2002), while high LOOH levels disturb the intestinal homeostasis to such 
an extent that pro-apoptotic processes cannot be stopped even after restoration of redox 
balance (Wang et al., 2000). In addition, LOOH cause damage to intestinal cell membranes in 
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vitro, as well as single- and double-strand DNA breaks and may influence the activity of AO 
enzymes (Wijeratne & Cuppett, 2006). 
Since the intestinal mucosa interfaces with the lumen, which is open to the exterior 
environment and deeper layers of the intestinal wall, it represents a crucial protective 
barrier against potential toxic agents. In addition to the nutrients, the intestinal mucosa is 
constantly exposed to oxidants, mutagens and carcinogens from the diet, as well as to 
endogenous ROS. Several protective mechanisms preserve cellular integrity and tissue 
homeostasis: the intestine is able to maintain high concentrations of antioxidants and to up-
regulate AO enzymes, while apoptosis is induced to eliminate spent or damaged enterocytes 
(Aw, 1999). The GSH redox cycle is the key mechanism of LOOH scavenging in the intestine 
(Aw, 2005).  GSH is a powerful antioxidant that acts as a detoxifier of endogenous and 
exogenous ROS. Published data indicate that epithelial cells of the small and large intestine 
are highly dependent on GSH. It was demonstrated that in mice treated with L-buthionine 
SR-sulfoximine (BSO), a specific inhibitor of GSH synthesis, a significant degeneration of 
enterocytes is induced, as a consequence of GSH deficiency (Mårtensson et al., 1990). High 
levels of GSH are found in many tissues, including the intestine. Normal concentrations of 
intracellular GSH are maintained by de novo synthesis, regeneration from GSSG or through 
import via the Na+-dependent transport system. GSH transport into the cell is demonstrated 
in several cell types, including enterocytes (Aw, 1994; Mårtensson et al., 1990). The ability of 
enterocytes to import luminal GSH is important for the intestinal thiol balance, especially in 
pro-oxidative conditions, since the human diet is extremely various concerning the GSH and 
LOOH content. In a healthy system, where GSH is not limiting, intracellular metabolism of 
LOOH is enhanced, decreasing luminal LOOH retention and excretion into lymph. On the 
contrary, if GSH is insufficient, LOOH catabolism decreases and their luminal retention and 
lymphatic transport are promoted (LeGrand and Aw, 2001). 
In this investigation a significantly lower GSH concentration (~ 40-50 %) was found in the 
intestinal mucosa with villous atrophy compared to the normal mucosa and mucosa with 
milder lesions.  The decreased GSH concentration is followed by decreased activities of GPx 
and GR and increased LOOH concentration. Our results are in accordance with the previous 
data reporting a significant decrease of GPx activity in mucosa of children with severe 
villous atrophy (Ståhlberg et al., 1988). Similar data have come from in vitro studies 
investigating the effects of gliadin on intestinal cells in culture (Dolfini et al., 2002; Dolfini et 
al., 2005). The experiments of Rivabene and coworkers have shown that the antiproliferative 
effects of gliadin are associated with pro-oxidative changes in the cell, such as elevated 
LOOH levels, decreased GSH concentration and a loss of SH- groups in proteins; the 
administration of BSO has demonstrated that the extent of these changes depended on the 
basal redox state of enterocytes, primarily their GSH content (Rivabene et al., 1999). These 
results imply that higher GSH concentrations could, at least partly, modify cell susceptibility 
to the toxic effects of gliadin. 
GSH is not only an enzyme cofactor, but can also react directly with free radicals and is 
involved in recycling of other chain breaking antioxidants, such as vitamin E, whose 
concentration is reduced in celiac patients on GFD (Odetti et al., 1998). One of the extremely 
important roles of GSH is detoxification of various endogenous and exogenous toxins by 
GSH-S-transferases (GST), which use GSH as a cofactor. GSH deficiency should also 
influence these enzymes. Previous investigations have reported reduced total GST activity, 
 
Antioxidant Status of the Celiac Mucosa: Implications for Disease Pathogenesis 
 
29 
as well as GST class levels, although GSH concentration was not significantly altered in 
comparison to the control values (Wahab et al., 2001). In an in vitro study gliadin provoked 
a reduction in GSH content and gliadin concentration-related decrease in the activity of 
GPx, GR and GSH-S-transferases (Elli et al., 2003).  
Since the activities of GPx and GR in our study were inversely related to GSH concentration, 
a decrease in these activities in patients with villous atrophy could be a consequence of GSH 
deficiency. In addition, as Gpx is a selenium-dependent enzyme, low Se levels can also 
influence its activity. Previous investigations have shown that GPx activity did not change 
in the conditions of elevated LOOH levels, pointing to the influence of dietary selenium on 
the glutathione peroxidase system of the gastrointestinal tract in rats (Reddy & Tappel, 1974; 
Vilas et al., 1976). Selenium deficiency has already been reported in celiac patients (Stazi & 
Trinti, 2010; Yuce et al., 2004). Several studies have also reported a strong correlation 
between Gpx activity and Se level in the blood, especially when Se concentration is low (< 
80 g/L) (Lloyd et al., 1989; McKenzie at al., 1978). Aw and coworkers suggested that GPx 
and GR per se are not limited in the catabolism of LOOH in the intestine. The kinetics of 
these enzymes and the extent of intracellular LOOH degradation depend principally on the 
availability of cellular reductants (GSH and NADPH) (Aw & Williams, 1992; Aw et al., 
1992). It has been shown that a disturbed intestinal GSH/GSSG ratio is involved in the 
pathogenesis of chronic intestinal inflammation in mice with severe combined 
immunodeficiency (SCID) reconstituted with CD4+CD45Rbhigh T-lymphocytes (Aw, 2005). 
The loss of GSH redox balance preceded tissue hyperplasia, mucosal inflammation and the 
symptoms of clinical colitis, suggesting that redox imbalance may be a contributor rather 
than the consequence of disease.  
Similar to previous reports, the results of our study indicate that oxidative stress is strongly 
associated with celiac disease and could be an important factor in disease pathogenesis. 
The AO status of patients with villous atrophy is severely disturbed. GSH deficiency and 
decreased activities of GSH-dependent enzymes significantly reduce the AO capacity of 
these patients, which is reflected in elevated LOOH levels. The AO status of patients with 
milder mucosal lesions (Marsh 1+2 group) was not significantly altered compared to 
patients with normal mucosa. However, it should be emphasized that even in this group 
LOOH concentration was significantly elevated pointing out the incapacity of the GSH 
redox cycle to efficiently eliminate peroxides. The LOOH challenge may provoke 
perturbations of normal intestinal cell proliferation, differentiation and apoptotic 
responses, contributing to the increased risk of malignancy in untreated celiac patients. It is 
well known that GSH is indispensable for normal function of intestinal epithelium. Since 
enterocytes are capable of absorbing dietary GSH from the intestinal lumen, it has been 
demonstrated that oral administration of GSH elevates GSH concentration in small and 
large intestinal mucosa of mice, protecting the tissue from GSH deficiency provoked by 
BSO (Mårtensson et al., 1990). We could speculate that the oral administration of GSH 
would be beneficial for protection of the intestinal epithelium from damage occurring in 
inflammatory disorders, such as celiac disease, as well as ischemia, chemotherapy or 
radiation. In addition, as GSH can be regenerated from other antioxidants (Lenton et al, 
2003), a diet enriched with natural antioxidants, as well as appropriate supplements, could 
be important complements to the classic GFD. Furthermore, since GPx is more susceptible 
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to the influence of dietary supplements than other AO enzymes (Andersen et al., 1997), 
administration of antioxidants and Se could enhance GPx activity and promote LOOH 
scavenging in celiac patients.  
Previous data concerning correlations between the activities of AO enzymes and histological 
changes characteristic of celiac disease are limited. Wahab and coworkers (2001) found 
decreased levels and activities of GST in small intestinal mucosa of celiac patients in 
comparison to the healthy individuals, which were proportional to the degree of mucosal 
damage. Similarly, the activity of uridine 5'-diphospho-glucuronosyltransferase, an enzyme 
that detoxifies some noxious compounds by catalyzing their addition to glucuronic acid, 
was also reduced in the intestinal mucosa of patients with celiac disease (Goerres et al., 
2006). On the contrary, plasma concentrations of end products of NO metabolism in celiac 
patients were elevated and correlated with the histological changes of mucosa (Murray et 
al., 2003; Spencer et al., 2004). The results of our study show that the severity of the mucosal 
lesion in celiac patients significantly correlated with all analyzed parameters of AO status. 
Positive correlations were found between severity of histological damage and the activities 
of both SODs, as well as LOOH concentration. The activities of CAT, GPx and GR and the 
concentration of GSH inversely correlated with the degree of the mucosal lesion. 
Concerning the fact that the severity of histological damage is reflective of the AO status in 
the intestinal mucosa of celiac patients and since similar changes of the AO status in 
peripheral blood have already been reported (Stojiljković et al., 2007), we suggest that new, 
noninvasive methods, involving analysis of AO parameters, could be developed for 
prediction and follow-up of histological changes in patients with celiac disease. In addition, 
nutritional evaluation should be performed in celiac patients at least annually, to monitor 
the mucosal damage and the effectiveness of GFD. 
5. Conclusions 
Our results demonstrate that oxidative stress is implicated in the pathogenesis of celiac 
disease. A significant disturbance in AO status occurs in patients affected by celiac disease, 
especially those with the advanced mucosal damage. Changes of AO status significantly 
correlate with the severity of histological damage. A seriously impaired AO capacity for 
degradation of lipid hydroperoxides may persist even after several years of GFD. A diet rich 
in natural antioxidants as well as appropriate dietary supplements could be beneficial for 
full mucosal healing of celiac patients 
6. Acknowledgement 
This work received the financial support of the Ministry of Education and Science of the 
Republic of Serbia (Grants III 41027 and OI 173041). 
7. References 
Andersen, H.R., Nielsen, J.B., Nielsen, F. & Grandjean, P. (1997). Antioxidative enzyme 
activities in human erythrocytes. Clin. Chem., Vol. 43, No. 4, (Apr 1997), pp. (562-
568) 
 
Antioxidant Status of the Celiac Mucosa: Implications for Disease Pathogenesis 
 
31 
Aw, T.Y. & Williams, M.W. (1992). Intestinal absorption and lymphatic transport of 
peroxidized lipids in rats: effect of exogenous GSH. Am. J. Physiol., Vol. 263, No. 5, 
(Nov 1992), pp. (665-672) 
Aw, T.Y. (1994). Biliary glutathione promotes the mucosal metabolism of luminal    
peroxidized lipids by rat small intestine in vivo. J. Clin. Invest., Vol. 94, No. 3, (Sep 
1994), pp. (1218-1225) 
Aw, T.Y. (1998). Determinants of intestinal detoxication of lipid hydroperoxides. Free Radic. 
Res., Vol. 128, No. 6, (Jun 1998), pp. (637-646) 
Aw, T.Y. (1999). Molecular and cellular responses to oxidative stress and changes in 
oxidation-reduction imbalance in the intestine. Am. J. Clin. Nutr. Vol. 70, No. 4, (Oct 
1999), pp. (557-565) 
Aw, T.Y. (2005). Intestinal glutathione: determinant of mucosal peroxide transport, 
metabolism, and oxidative susceptibility. Toxicol. Appl. Pharmacol., Vol. 204, No. 3, 
(May 2005), pp. (320-328) 
Aw, T.Y., Williams, M.W. & Gray, L. (1992). Absorption and lymphatic transport of 
peroxidized lipids by rat small intestine in vivo: role of mucosal GSH. Am. J. 
Physiol., Vol. 262, No. 1, (Jan 1992), pp. ( 99-106) 
Babior, B.M. (1984). The respiratory burst of phagocytes. J. Clin. Invest, Vol. 73, No. 3, (Mar 
1984), pp. (599-601) 
Beckman, K.B. & Ames, B.N. (1997). Oxidative decay of DNA. J. Biol. Chem, Vol. 272, No. 32, 
(Aug 1997), pp. (19633-19636) 
Beutler, E. (1982). Catalase, In: Red Cell Metabolism, a manual of Biochemical Methods, Beutler, 
E. (ed.), pp. (105-106), Grune and Stratton, New York 
Bilotta, J.J. & Waye, J.D. (1989). Hydrogen peroxide enteritis: the "snow white" sign. 
Gastrointest. Endosc, Vol. 35, No. 5, (Sep-Oct 1989), pp. (428-430) 
Blokhina, O., Virolainen, E. & Fagerstedt, K.V. (2003). Antioxidants, oxidative damage and 
oxygen deprivation stress: a review. Ann. Bot, Vol. 91, Spec No, (Jan 2003), pp. (179-
194) 
Boda, M., Németh, I. & Boda, D. (1999). The caffeine metabolic ratio as an index of xanthine 
oxidase activity in clinically active and silent celiac patients. J. Pediatr. 
Gastroenterol. Nutr, Vol. 29, No. 5, (Nov 1999), pp. (546-550) 
Buhner, S., Buning, C., Genschel, J., Kling, K., Herrmann, D., Dignass, A., Kuechler, I., 
Krueger, S., Schmidt, H.H. & Lochs, H. (2006). Genetic basis for increased intestinal 
permeability in families with Crohn's disease: role of CARD15 3020insC mutation? 
Gut, Vol. 55, No. 3, (Mar 2006), pp. (342-347) 
Burdon, R.H. (1996). Control of cell proliferation by reactive oxygen species. Biochem. Soc. 
Trans, Vol. 24, No. 4, (Nov 1996), pp. (1028-1032) 
Davies, K.J. (1987). Protein damage and degradation by oxygen radicals. I. General aspects. 
J. Biol. Chem, Vol. 262, No. 20, (Jul 1987), pp. (9895-9901) 
Dolfini, E., Elli, L., Dasdia, T., Bufardeci, B., Colleoni, M.P., Costa, B., Floriani, I., Falini, M.L., 
Guerrieri, N., Forlani, F. & Bardella, M.T. (2002). In vitro cytotoxic effect of bread 
wheat gliadin on the LoVo human adenocarcinoma cell line. Toxicol. In Vitro, Vol. 
16, No. 4, (Aug 2002), pp. ( 331-337) 
 
Celiac Disease – From Pathophysiology to Advanced Therapies 
 
32
Dolfini, E., Elli, L., Roncoroni, L., Costa, B., Colleoni, M.P., Lorusso, V., Ramponi, S., 
Braidotti, P., Ferrero, S., Falini, M.L. & Bardella, M.T. (2005). Damaging effects of 
gliadin on three-dimensional cell culture model. World J. Gastroenterol., Vol. 11, No. 
38, (Oct 2005), pp. (5973-5977) 
Dryden, G.W. Jr., Deaciuc, I., Arteel, G. &  McClain, CJ. (2005). Clinical implications of 
oxidative stress and antioxidant therapy. Curr. Gastroenterol. Re, Vol. 7, No. 4, 
(Aug 2005), pp. (308-316) 
Dugas, B., Dugas, N., Conti, M., Calenda, A., Pino, P., Thomas, Y., Mazier, D. & Vouldoukis, 
I. (2003). Wheat gliadin promotes the interleukin-4-induced IgE production by 
normal human peripheral mononuclear cells through a redox-dependent 
mechanism. Cytokine, Vol. 21, No. 6, (Mar 2003), pp. (270-280) 
Eaton, J.W. (1991). Catalases and peroxidases and glutathione and hydrogen peroxide: 
mysteries of the bestiary. J. Lab. Clin. Med., Vol. 118, No. 1, (Jul 1991), pp. (3–4)  
Egler, R.A., Fernandes, E., Rothermund, K., Sereika, S., de Souza-Pinto, N., Jaruga, P., 
Dizdaroglu, M. & Prochownik, E.V. (2005). Regulation of reactive oxygen species, 
DNA damage, and c-Myc function by peroxiredoxin 1. Oncogene, Vol. 24, No. 54, 
(Dec 2005), pp. (8038-8050) 
Elli, L., Dolfini, E. & Bardella, M.T. (2003). Gliadin cytotoxicity and in vitro cell cultures. 
Toxicol Lett. Vol. 146, No. 1, (Dec 2003), pp. (1-8)  
Elstner, E.F. (1987). Metabolism of activated oxygen species, In: Biochemistry of plants, Vol. 11, 
Davies, D.D. (ed.), pp. (253–315), Academic Press, London  
Farinati, F., Cardin, R., Russo, V.M., Busatto, G., Franco, M. & Rugge, M. (2003). 
Helicobacter pylori CagA status, mucosal oxidative damage and gastritis 
phenotype: a potential pathway to cancer? Helicobacter, Vol. 8, No. 3, (Jun 2003), pp. 
(227-234) 
Fries, W., Renda, M.C., Lo Presti, M.A,, Raso, A., Orlando, A., Oliva, L., Giofré, M.R., 
Maggio, A., Mattaliano, A., Macaluso, A. & Cottone, M. (2005). Intestinal 
permeability and genetic determinants in patients, first-degree relatives, and 
controls in a high-incidence area of Crohn's disease in Southern Italy. Am. J. 
Gastroenterol, Vol. 100, No. 12, (Dec 2005), pp. (2730-2736) 
Goerres, M., Roelofs, H.M., Jansen, J.B. & Peters, W.H. (2006). Deficient UDP-
glucuronosyltransferase detoxification enzyme activity in the small intestinal 
mucosa of patients with coeliac disease. Aliment. Pharmacol. Ther., Vol. 23, No. 2, 
(Jan 2006), pp. (243-246) 
Gotoh, Y., Nodam T., Iwakiri, R., Fujimoto, K., Rhoads, C.A. & Aw, T.Y. (2002). Lipid 
peroxide-induced redox imbalance differentially mediates CaCo-2 cell proliferation 
and growth arrest. Cell Prolif., Vol.  35, No. 4, (Aug 2002), pp. (221-235) 
Gressier, B., Lebegue, S., Brunet, C., Luyckx, M., Dine, T., Cazin, M. & Cazin, J.C.( 1994). Pro-
oxidant properties of methotrexate: evaluation and prevention by an anti-oxidant 
drug. Pharmazie, Vol. 49, No. 9, (Sep 1994), pp. (679-681) 
Grisham, M.B., Ware, K., Marshall, S., Yamada, T. & Sandhu, I.S. (1992). Prooxidant 
properties of 5-aminosalicylic acid. Possible mechanism for its adverse side effects. 
Dig. Dis. Sci, Vol. 37, No. 9, (Sep 1992), pp. (1383-1389) 
 
Antioxidant Status of the Celiac Mucosa: Implications for Disease Pathogenesis 
 
33 
Halliwell, B. & Gutteridge, J.M.C. (1989). Free radicals in Biology and Medicine, Claredon Press, 
Oxford 
Halliwell, B. (1991). Reactive oxygen species in living systems: source, biochemistry, and 
role in human disease. Am. J. Med, Vol. 91, No. 3C, (Sep 1991), pp. (14-22) 
Hendrickson, B.A., Gokhale, R. & Cho, J.H. (2002). Clinical aspects and pathophysiology of 
inflammatory bowel disease. Clin. Microbiol. Rev, Vol. 15, No. 1, (Jan 2002), pp. 
(79-94) 
Iatropoulos, M.J. (1986). Morphology of the gastrointestinal tract, In: Gastrointestinal 
toxicology , Rozman, K. & Hannenen, O. (Eds.), pp. (246-266), Elsevier, Amsterdam  
Imai, H. & Nakagawa, Y. (2003). Biological significance of phospholipid hydroperoxide 
glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic. Biol Med., 
Vol. 34, No. 2, (Jan 2003), pp. (145-169) 
Jones, D.P., Carlson, J.L., Mody, V.C., Cai, J., Lynn, M.J. & Sternberg, P. (2000). Redox state 
of glutathione in human plasma. Free Radic. Biol. Med, Vol. 28, No. 4, (Feb 2000), pp. 
(625-635) 
Koch, T.R., Schulte-Bockholt, A., Otterson, M.F., Telford, G.L., Stryker, S.J., Ballard, T. & 
Opara, E.C. (1996). Decreased vasoactive intestinal peptide levels and glutathione 
depletion in acquired megacolon. Dig. Dis. Sci,Vol. 41, No. 7, (Jul 1996), pp. (1409-
1416) 
Kroemer, G., Dallaporta, B. & Resche-Rigon, M. 1998: The mitochondrial death/life 
regulator in apoptosis and necrosis. Annu. Rev. Physiol, Vol. 60, (1998), pp. (619-642) 
LeGrand, T.S. & Aw, T.Y. (2001). Intestinal absorption of lipid hydroperoxides, In: Intestinal 
lipid metabolism, Mansbach, C., Kuksis, A. & Tso, P. (Eds.), pp. (351-366), Plenum 
Publishing Corporation, New York 
Lenton, K.J., Sané, A.T., Therriault, H., Cantin, A.M., Payette, H. &, Wagner, J.R. (2003). 
Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency. 
Am. J. Clin. Nutr., Vol. 77, No. 1, (Jan 2003), pp. (189-195) 
Lloyd, B., Robson, E., Smith, I. & Clayton, B.E. (1989). Blood selenium concentrations and 
glutathione peroxidase activity. Arch. Dis. Child., Vol. 64, No. 3, (Mar 1989), (352-
356) 
Maiuri MC, De Stefano D, Mele G, Iovine B, Bevilacqua MA, Greco L, Auricchio S, 
Carnuccio, R. (2003). Gliadin increases iNOS gene expression in interferon-gamma-
stimulated RAW 264.7 cells through a mechanism involving NF-kappa B. Naunyn 
Schmiedebergs Arch. Pharmacol. Vol. 368, No. 1, (Jul 2003),  (63-71) 
Marsh, M.N. & Crowe, P.T. (1995). Morphology of the mucosdal lesion in gluten sensitivity. 
Baillieres Clin. Gastroenterol, Vol. 9, No. 2, (Jun 1995), pp. (273-293) 
Mårtensson, J., Jain, A. & Meister, A. (1990). Glutathione is required for intestinal function. 
Proc. Natl. Acad. Sci. U S A., Vol. 87, No. 5, (Mar 1990), pp. (1715-1719) 
McKenzie, R.L., Rea, H.M., Thomson, C.D. & Robinson, M.F. (1978). Selenium concentration 
and glutathione peroxidase activity in blood of New Zealand infants and children. 
Am. J. Clin. Nutr., Vol. 31, No. 8, (Aug 1978), pp. (1413-1418) 
Meyer, C.T., Brand, M., DeLuca, V.A. & Spiro, H.M. (1981). Hydrogen peroxide colitis: a 
report of three patients. J. Clin. Gastroenterol, Vol. 3, No. 1, (Mar 1981), pp.  (31-35) 
 
Celiac Disease – From Pathophysiology to Advanced Therapies 
 
34
Mignotte, B. & Vayssiere, J.L. (1998). Mitochondria and apoptosis. Eur. J. Biochem, Vol. 252, 
No. 1, (Feb 1998), pp. (1-15) 
Murray, I.A., Bullimore, D.W. & Long, R.G. (2003). Fasting plasma nitric oxide products in 
coeliac disease. Eur. J. Gastroenterol. Hepatol., Vol. 15, No. 10, (Oct 2003), pp. (1091-
1095) 
Oberhuber, G., Granditsch, G. & Vogelsang, H. (1999). The histopathology of coeliac disease: 
time for a standardized report scheme for pathologists. Eur. J. Gastroenterol. Hepatol, 
Vol. 11, No. 10, (Oct 1999), pp. (1185-1194) 
Odetti, P., Valentini, S., Aragno, I., Garibaldi, S., Pronzato, M.A., Rolandi, E. & Barreca, T. 
(1998). Oxidative stress in subjects affected by celiac disease. Free Radic. Res, Vol. 29, 
No. 1, (Jul 1998), pp. (17-24) 
Opara, E.C., (2003). Oxidative stress, In: Colonic Diseases, Koch, T.R. (ed.), pp.  (179-189), 
Humana Press, Totowa NJ 
Otamiri, T. & Sjödahl, R. (1991). Oxygen radicals: their role in selected gastrointestinal 
disorders. Dig. Dis, Vol. 9. No. 3,  (n.d. 1991), pp. (133-141) 
Pickett, J.P., Pendergrass, R.E., Bradford, W.D. & Elchlepp, J.G. (1970). Localization of 
xanthine oxidase in rat duodenum; fixation of sections instead of blocks. Stain. 
Technol. Vol. 45, No. 1, (Jan 1970), pp. (35-36) 
Rao, R.K., Baker, R.D., Baker, S.S., Gupta, A. & Holycross, M. (1997). Oxidant-induced 
disruption of intestinal epithelial barrier function: role of protein tyrosine 
phosphorylation. Am. J. Physiol, Vol. 273, No. 4 Pt 1, (Oct 1997), pp. (812-823) 
Reddy, K. & Tappel, A.L. (1974). Effect of dietary selenium and autoxidized lipids on the 
glutathione peroxidase system of gastrointestinal tract and other tissues in the rat. 
J. Nutr., Vol. 104, No. 8, (Aug 1974), pp. (1069-1078) 
Rezaie, A., Ghorbani, F., Eshghtork, A., Zamani ,M.J., Dehghan, G., Taghavi, B., Nikfar, S., 
Mohammadirad, A., Daryani, N.E. & Abdollahi, M. (2006). Alterations in salivary 
antioxidants, nitric oxide, and transforming growth factor-beta 1 in relation to 
disease activity in Crohn's disease patients. Ann. N. Y. Acad. Sci, No. 1091, (Dec 
2006), pp. (110-122) 
Rezaie, A., Parker, R.D. & Abdollahi, M. (2007). Oxidative stress and pathogenesis of 
inflammatory bowel disease: an epiphenomenon or the cause? Dig. Dis. Sci, Vol. 52, 
No. 9, (Sep 2007), pp. (2015-2021) 
Riedle, B. & Kerjaschki, D. (1997). Reactive oxygen species cause direct damage of 
Engelbreth-Holm-Swarm matrix. Am. J. Pathol, Vol. 151, No. 1, (Jul 1997), pp. (215-
231) 
Rivabene, R., Mancini, E. & De Vincenzi, M. (1999). In vitro cytotoxic effect of wheat gliadin-
derived peptides on the Caco-2 intestinal cell line is associated with intracellular 
oxidative imbalance: implications for coeliac disease. Biochim. Biophys. Acta, Vol. 
1453, No. 1, (Jan 1999), pp. (152-160) 
Sarnesto, A., Linder, N. & Raivio, K.O. (1996). Organ distribution and molecular forms of 
human xanthine dehydrogenase/xanthine oxidase protein. Lab. Invest. Vol. 74, No. 
1, (Jan 1996), pp. (48-56) 
 
Antioxidant Status of the Celiac Mucosa: Implications for Disease Pathogenesis 
 
35 
Spencer, H.L., Daniels, I., Shortland, J., Long, R.G.& Murray, I.A. (2004). Effect of a gluten-
free diet on plasma nitric oxide products in coeliac disease. Scand. J. Gastroenterol., 
Vol. 39, No. 10, (Oct 2004), (941-945) 
Spiteller, G. (2007). The important role of lipid peroxidation processes in aging and age 
dependent diseases. Mol. Biotechnol, Vol. 37, No. 1, (Sep 2007), pp. (5-12) 
Ståhlberg, M.R. & Hietanen, E. (1991). Glutathione and glutathione-metabolizing enzymes in 
the erythrocytes of healthy children and in children with insulin-dependent 
diabetes mellitus, juvenile rheumatoid arthritis, coeliac disease and acute 
lymphoblastic leukaemia. Scand. J. Clin. Lab. Invest, Vol. 51, No. 2, (Apr 1991), pp. 
(125-130) 
Ståhlberg, M.R., Hietanen, E. & Mäki, M. (1988). Mucosal biotransformation rates in the 
small intestine of children. Gut, Vol. 29, No. 8, (Aug 1988), pp. (1058-1063) 
Stazi, A.V. & Trinti, B. (2010). Selenium status and over-expression of interleukin-15 in celiac 
disease and autoimmune thyroid diseases. Ann. Ist. Super. Sanita, Vol. 46, No. 4, 
(n.d. 2010), pp.  (389-399) 
Stojiljković, V., Todorović, A., Pejić, S., Kasapović, J., Saičić, Z.S., Radlović, N. & Pajović, S.B. 
(2009). Antioxidant status and lipid peroxidation in small intestinal mucosa of 
children with celiac disease. Clin. Biochem., Vol. 42, No. 13-14, (Sep 2009), pp. (1431-
1437) 
Stojiljković, V., Todorović, A., Radlović, N., Pejić, S., Mladenović, M., Kasapovi, J. & Pajović, 
S.B. (2007). Antioxidant enzymes, glutathione and lipid peroxidation in peripheral 
blood of children affected by coeliac disease. Ann. Clin. Biochem, Vol. 44, No. Pt 6, 
(Nov 2007), pp. (537-543) 
Thannickal, V.J. & Fanburg, B.L. (2000). Reactive oxygen species in cell signaling. Am. J. 
Physiol. Lung Cell Mol. Physiol, Vol. 279, N0. 6, (Dec 2000), pp. (1005-1028) 
Tucková, L., Novotná, J., Novák, P., Flegelová, Z., Kveton, T., Jelínková, L., Zídek, Z., Man, 
P. & Tlaskalová-Hogenová, H. (2002). Activation of macrophages by gliadin 
fragments: isolation and characterization of active peptide. J. Leukoc. Biol, Vol. 71, 
No. 4, (Apr 2002), pp. (625-631) 
Valko, M., Izakovic, M., Mazur, M., Rhodes, C.J. & Telser, J. (2004). Role of oxygen radicals 
in DNA damage and cancer incidence. Mol. Cell Biochem, Vol. 266, No. 1-2, (Nov 
2004), pp. (37-56) 
Vilas, N.N., Bell, R.R. & Draper, H.H. (1976). Influence of dietary peroxides, selenium and 
vitamin E on glutathione peroxidase of the gastrointestinal tract. J. Nutr,. Vol. 106, 
No. 5, (May 1976), pp. (589-596) 
Wahab, P.J., Peters, W.H., Roelofs, H.M. & Jansen, J.B. (2001). Glutathione S-transferases in 
small intestinal mucosa of patients with coeliac disease. Jpn. J. Cancer Res., Vol. 92, 
No. 3, (Mar 2001), pp. (279-284) 
Walker-Smith, J.A. (1990). Revised criteria for diagnosis of coeliac disease. Report of 
Working Group of European Society of Paediatric Gastroenterology and Nutrition. 
Arch. Dis Child, Vol. 65, No. 8, (Aug 1990), pp. (909-911) 
Wang, T.G., Gotoh, Y., Jennings, M.H., Rhoads, C.A. & Aw, T.Y. (2000). Lipid 
hydroperoxide-induced apoptosis in human colonic CaCo-2 cells is associated with 
 
Celiac Disease – From Pathophysiology to Advanced Therapies 
 
36
an early loss of cellular redox balance. FASEB J., Vol. 14, No. 11, (Aug 2000), pp. 
(1567-1576) 
Wijeratne, S.S. & Cuppett, S.L. (2006). Lipid hydroperoxide induced oxidative stress damage 
and antioxidant enzyme response in Caco-2 human colon cells. J. Agric. Food Chem., 
Vol. 54, No. 12, (Jun 2006), pp. (4476-4481) 
Yüce, A., Demir, H., Temizel, I.N. & Koçak, N. (2004). Serum carnitine and selenium levels 
in children with celiac disease. Indian J. Gastroenterol., Vol. 23, No. 3, (May-Jun 
2004), pp. (87-88) 
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
